Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
17.38
-0.28 (-1.59%)
At close: Jan 13, 2026, 4:00 PM EST
17.38
0.00 (0.00%)
After-hours: Jan 13, 2026, 7:39 PM EST

Oscar Health Statistics

Total Valuation

Oscar Health has a market cap or net worth of $4.59 billion. The enterprise value is $3.19 billion.

Market Cap4.59B
Enterprise Value 3.19B

Important Dates

The next confirmed earnings date is Tuesday, February 10, 2026, before market open.

Earnings Date Feb 10, 2026
Ex-Dividend Date n/a

Share Statistics

Oscar Health has 264.37 million shares outstanding. The number of shares has decreased by -10.34% in one year.

Current Share Class 228.70M
Shares Outstanding 264.37M
Shares Change (YoY) -10.34%
Shares Change (QoQ) +1.46%
Owned by Insiders (%) 3.33%
Owned by Institutions (%) 55.21%
Float 216.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.39
Forward PS 0.36
PB Ratio 4.43
P/TBV Ratio 4.49
P/FCF Ratio 6.25
P/OCF Ratio 5.97
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.28
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 4.33

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.72.

Current Ratio 0.95
Quick Ratio 0.90
Debt / Equity 0.72
Debt / EBITDA n/a
Debt / FCF 1.01
Interest Coverage -8.51

Financial Efficiency

Return on equity (ROE) is -22.24% and return on invested capital (ROIC) is -7.97%.

Return on Equity (ROE) -22.24%
Return on Assets (ROA) -2.57%
Return on Invested Capital (ROIC) -7.97%
Return on Capital Employed (ROCE) -11.89%
Revenue Per Employee $4.70M
Profits Per Employee -$101,703
Employee Count2,400
Asset Turnover 2.21
Inventory Turnover n/a

Taxes

In the past 12 months, Oscar Health has paid $5.45 million in taxes.

Income Tax 5.45M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +22.57% in the last 52 weeks. The beta is 1.90, so Oscar Health's price volatility has been higher than the market average.

Beta (5Y) 1.90
52-Week Price Change +22.57%
50-Day Moving Average 15.92
200-Day Moving Average 16.22
Relative Strength Index (RSI) 61.06
Average Volume (20 Days) 7,270,354

Short Selling Information

The latest short interest is 25.11 million, so 9.50% of the outstanding shares have been sold short.

Short Interest 25.11M
Short Previous Month 31.32M
Short % of Shares Out 9.50%
Short % of Float 11.61%
Short Ratio (days to cover) 3.21

Income Statement

In the last 12 months, Oscar Health had revenue of $11.29 billion and -$244.09 million in losses. Loss per share was -$1.02.

Revenue11.29B
Gross Profit 1.82B
Operating Income -210.34M
Pretax Income -238.31M
Net Income -244.09M
EBITDA -180.10M
EBIT -210.34M
Loss Per Share -$1.02
Full Income Statement

Balance Sheet

The company has $3.04 billion in cash and $742.06 million in debt, with a net cash position of $1.41 billion or $5.32 per share.

Cash & Cash Equivalents 3.04B
Total Debt 742.06M
Net Cash 1.41B
Net Cash Per Share $5.32
Equity (Book Value) 1.03B
Book Value Per Share 3.92
Working Capital -214.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $769.77 million and capital expenditures -$34.13 million, giving a free cash flow of $735.64 million.

Operating Cash Flow 769.77M
Capital Expenditures -34.13M
Free Cash Flow 735.64M
FCF Per Share $2.78
Full Cash Flow Statement

Margins

Gross margin is 16.16%, with operating and profit margins of -1.86% and -2.16%.

Gross Margin 16.16%
Operating Margin -1.86%
Pretax Margin -2.11%
Profit Margin -2.16%
EBITDA Margin -1.60%
EBIT Margin -1.86%
FCF Margin 6.52%

Dividends & Yields

Oscar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 10.34%
Shareholder Yield 10.34%
Earnings Yield -5.31%
FCF Yield 16.01%
Dividend Details

Analyst Forecast

The average price target for Oscar Health is $17.00, which is -2.19% lower than the current price. The consensus rating is "Hold".

Price Target $17.00
Price Target Difference -2.19%
Analyst Consensus Hold
Analyst Count 7
Revenue Growth Forecast (5Y) 14.27%
EPS Growth Forecast (5Y) 82.18%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4